home.social

#q1earnings — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #q1earnings, aggregated by home.social.

  1. Hite Jinro's Q1 operating profit fell 10.8% year-on-year to 55.9 billion won amid weakening alcohol consumption, though the company emphasized sequential improvements through cost efficiency measures and plans to boost sales activities ahead of the peak season.
    #YonhapInfomax #HiteJinro #OperatingProfit #Q1Earnings #AlcoholConsumption #CostEfficiency #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

  2. Hite Jinro's Q1 operating profit fell 10.8% year-on-year to 55.9 billion won amid weakening alcohol consumption, though the company emphasized sequential improvements through cost efficiency measures and plans to boost sales activities ahead of the peak season.
    #YonhapInfomax #HiteJinro #OperatingProfit #Q1Earnings #AlcoholConsumption #CostEfficiency #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

  3. Hite Jinro's Q1 operating profit fell 10.8% year-on-year to 55.9 billion won amid weakening alcohol consumption, though the company emphasized sequential improvements through cost efficiency measures and plans to boost sales activities ahead of the peak season.
    #YonhapInfomax #HiteJinro #OperatingProfit #Q1Earnings #AlcoholConsumption #CostEfficiency #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

  4. Hite Jinro's Q1 operating profit fell 10.8% year-on-year to 55.9 billion won amid weakening alcohol consumption, though the company emphasized sequential improvements through cost efficiency measures and plans to boost sales activities ahead of the peak season.
    #YonhapInfomax #HiteJinro #OperatingProfit #Q1Earnings #AlcoholConsumption #CostEfficiency #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

  5. Medpace navigates choppy waters in Q1 2026 earnings

    Medpace sees more cancellations in Q1 2026, impacting drug trial growth. Company raises full-year outlook despite challenges. What happens next?

    #Medpace #DrugTrials #ClinicalResearch #Q1Earnings #Biotech

    newsletter.tf/medpace-q1-2026-

  6. Medpace's Q1 2026 saw higher order cancellations compared to previous periods, making future growth uncertain. The company has raised its full-year financial forecast.

    #Medpace #DrugTrials #ClinicalResearch #Q1Earnings #Biotech
    newsletter.tf/medpace-q1-2026-

  7. FYI: Trade Desk beat Q1 estimates. Wall Street downgraded it anyway: The Trade Desk posted $689 million in Q1 2026 revenue on May 7, beating estimates but missing Q2 guidance and triggering a William Blair downgrade on Friday. ppc.land/trade-desk-beat-q1-es #TradeDesk #Q1Earnings #WallStreet #RevenueGrowth #StockMarket

  8. FYI: Trade Desk beat Q1 estimates. Wall Street downgraded it anyway: The Trade Desk posted $689 million in Q1 2026 revenue on May 7, beating estimates but missing Q2 guidance and triggering a William Blair downgrade on Friday. ppc.land/trade-desk-beat-q1-es #TradeDesk #Q1Earnings #WallStreet #RevenueGrowth #StockMarket

  9. FYI: Trade Desk beat Q1 estimates. Wall Street downgraded it anyway: The Trade Desk posted $689 million in Q1 2026 revenue on May 7, beating estimates but missing Q2 guidance and triggering a William Blair downgrade on Friday. ppc.land/trade-desk-beat-q1-es #TradeDesk #Q1Earnings #WallStreet #RevenueGrowth #StockMarket

  10. FYI: Trade Desk beat Q1 estimates. Wall Street downgraded it anyway: The Trade Desk posted $689 million in Q1 2026 revenue on May 7, beating estimates but missing Q2 guidance and triggering a William Blair downgrade on Friday. ppc.land/trade-desk-beat-q1-es #TradeDesk #Q1Earnings #WallStreet #RevenueGrowth #StockMarket

  11. ICYMI: AppLovin's $1.84B Q1 beats guidance as Axon platform opens to all in June: AppLovin posted Q1 2026 revenue of $1.84 billion, up 59% year-over-year, with net income doubling and the Axon platform set for a public launch in June 2026. ppc.land/applovins-1-84b-q1-be #AppLovin #Q1Earnings #TechNews #AxonPlatform #RevenueGrowth

  12. ICYMI: AppLovin's $1.84B Q1 beats guidance as Axon platform opens to all in June: AppLovin posted Q1 2026 revenue of $1.84 billion, up 59% year-over-year, with net income doubling and the Axon platform set for a public launch in June 2026. ppc.land/applovins-1-84b-q1-be #AppLovin #Q1Earnings #TechNews #AxonPlatform #RevenueGrowth

  13. ICYMI: AppLovin's $1.84B Q1 beats guidance as Axon platform opens to all in June: AppLovin posted Q1 2026 revenue of $1.84 billion, up 59% year-over-year, with net income doubling and the Axon platform set for a public launch in June 2026. ppc.land/applovins-1-84b-q1-be #AppLovin #Q1Earnings #TechNews #AxonPlatform #RevenueGrowth

  14. Dexcom Navigates Growth Amidst Cost Pressures, Analysts Eye Margin Expansion

    Dexcom's Q1 2026 revenue hit $1.19 billion, up 15%. See how rising costs might affect future profits.

    #Dexcom #CGM #Healthcare #Q1Earnings #MedicalDevices

    newsletter.tf/dexcom-q1-2026-r

  15. Dexcom Navigates Growth Amidst Cost Pressures, Analysts Eye Margin Expansion

    Dexcom's Q1 2026 revenue hit $1.19 billion, up 15%. See how rising costs might affect future profits.

    #Dexcom #CGM #Healthcare #Q1Earnings #MedicalDevices

    newsletter.tf/dexcom-q1-2026-r

  16. Dexcom Navigates Growth Amidst Cost Pressures, Analysts Eye Margin Expansion

    Dexcom's Q1 2026 revenue hit $1.19 billion, up 15%. See how rising costs might affect future profits.

    #Dexcom #CGM #Healthcare #Q1Earnings #MedicalDevices

    newsletter.tf/dexcom-q1-2026-r

  17. Dexcom Navigates Growth Amidst Cost Pressures, Analysts Eye Margin Expansion

    Dexcom's Q1 2026 revenue hit $1.19 billion, up 15%. See how rising costs might affect future profits.

    #Dexcom #CGM #Healthcare #Q1Earnings #MedicalDevices

    newsletter.tf/dexcom-q1-2026-r

  18. AppLovin's $1.84B Q1 beats guidance as Axon platform opens to all in June: AppLovin posted Q1 2026 revenue of $1.84 billion, up 59% year-over-year, with net income doubling and the Axon platform set for a public launch in June 2026. ppc.land/applovins-1-84b-q1-be #AppLovin #AxonPlatform #Q1Earnings #TechNews #StartupSuccess

  19. AppLovin's $1.84B Q1 beats guidance as Axon platform opens to all in June: AppLovin posted Q1 2026 revenue of $1.84 billion, up 59% year-over-year, with net income doubling and the Axon platform set for a public launch in June 2026. ppc.land/applovins-1-84b-q1-be #AppLovin #AxonPlatform #Q1Earnings #TechNews #StartupSuccess

  20. AppLovin's $1.84B Q1 beats guidance as Axon platform opens to all in June: AppLovin posted Q1 2026 revenue of $1.84 billion, up 59% year-over-year, with net income doubling and the Axon platform set for a public launch in June 2026. ppc.land/applovins-1-84b-q1-be #AppLovin #AxonPlatform #Q1Earnings #TechNews #StartupSuccess

  21. AppLovin's $1.84B Q1 beats guidance as Axon platform opens to all in June: AppLovin posted Q1 2026 revenue of $1.84 billion, up 59% year-over-year, with net income doubling and the Axon platform set for a public launch in June 2026. ppc.land/applovins-1-84b-q1-be #AppLovin #AxonPlatform #Q1Earnings #TechNews #StartupSuccess

  22. AppLovin's $1.84B Q1 beats guidance as Axon platform opens to all in June: AppLovin posted Q1 2026 revenue of $1.84 billion, up 59% year-over-year, with net income doubling and the Axon platform set for a public launch in June 2026. ppc.land/applovins-1-84b-q1-be #AppLovin #AxonPlatform #Q1Earnings #TechNews #StartupSuccess

  23. S-Oil Co. reports first-quarter operating profit of 1.23 trillion won ($1.04 billion), marking a return to profitability and significantly surpassing market expectations amid improved refining margins
    #YonhapInfomax #SOil #OperatingProfit #Q1Earnings #RefiningMargins #ProfitabilityTurnaround #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

  24. WALL STREET EDGES TOWARDS NEW PEAKS AS CORPORATE EARNINGS OUTPACE PROJECTIONS

    Why is Wall Street rising in May 2026? US stock market is near record highs. Q1 2026 company profits for Apple, Boeing, and others were better than expected, helping stocks.

    #wallstreet #stockmarket #q1earnings #may2026 #usstocks

    newsletter.tf/wall-street-rise

  25. WALL STREET EDGES TOWARDS NEW PEAKS AS CORPORATE EARNINGS OUTPACE PROJECTIONS

    Why is Wall Street rising in May 2026? US stock market is near record highs. Q1 2026 company profits for Apple, Boeing, and others were better than expected, helping stocks.

    #wallstreet #stockmarket #q1earnings #may2026 #usstocks

    newsletter.tf/wall-street-rise

  26. WALL STREET EDGES TOWARDS NEW PEAKS AS CORPORATE EARNINGS OUTPACE PROJECTIONS

    Why is Wall Street rising in May 2026? US stock market is near record highs. Q1 2026 company profits for Apple, Boeing, and others were better than expected, helping stocks.

    #wallstreet #stockmarket #q1earnings #may2026 #usstocks

    newsletter.tf/wall-street-rise

  27. WALL STREET EDGES TOWARDS NEW PEAKS AS CORPORATE EARNINGS OUTPACE PROJECTIONS

    Why is Wall Street rising in May 2026? US stock market is near record highs. Q1 2026 company profits for Apple, Boeing, and others were better than expected, helping stocks.

    #wallstreet #stockmarket #q1earnings #may2026 #usstocks

    newsletter.tf/wall-street-rise

  28. US stock market is going up in May 2026, close to new record highs. Many big companies earned more money than expected in Q1 2026. This positive trend is stronger than earlier forecasts.

    #wallstreet #stockmarket #q1earnings #may2026 #usstocks
    newsletter.tf/wall-street-rise

  29. US stock market is going up in May 2026, close to new record highs. Many big companies earned more money than expected in Q1 2026. This positive trend is stronger than earlier forecasts.

    #wallstreet #stockmarket #q1earnings #may2026 #usstocks
    newsletter.tf/wall-street-rise

  30. US stock market is going up in May 2026, close to new record highs. Many big companies earned more money than expected in Q1 2026. This positive trend is stronger than earlier forecasts.

    #wallstreet #stockmarket #q1earnings #may2026 #usstocks
    newsletter.tf/wall-street-rise

  31. US stock market is going up in May 2026, close to new record highs. Many big companies earned more money than expected in Q1 2026. This positive trend is stronger than earlier forecasts.

    #wallstreet #stockmarket #q1earnings #may2026 #usstocks
    newsletter.tf/wall-street-rise

  32. Thermo Fisher Navigates Mixed Q1 Amidst Clario Integration and Market Crosscurrents

    Thermo Fisher Scientific's Q1 2026 revenue hit $11.01 billion, beating estimates. The Clario acquisition closed early. See how it affects customers.

    #ThermoFisher, #Q1Earnings, #ClarioAcquisition, #Biotech, #ClinicalTrials

    newsletter.tf/thermo-fisher-q1